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B lymphocytes and other blood cells are formed within bone marrow under
the influence ofregulatory glycoproteins that may exist in soluble orinsolubilized
forms (1-3). Thus far, a number of factors have been found to augment the
formation and maturation of B lineage precursors in culture. These include (IL-
1, IFN-y, substances isolated from the serum ofyoung autoimmune mice, factors
associated with cyclic neutropenia, one or more factors made by narrow stromal
cells, IL-4, and TNF (1, 4, and Lee, G., unpublished observations). A pattern is
emerging whereby these substances selectively stimulate particular maturation
events and stages in B cell differentiation (1). However, little is known of
antagonists which might function to limit the progression of these events.
Transforming growth factor ,Q (TGF-#)' was originally described by its ability
toconfer anchorage independent growth on nonmalignant fibroblasts (5, 6), and
is synthesized and secreted by a variety ofcells (7-11). It has been found to have
stimulatory or inhibitory activities depending on target cell type and presence of
other growth factors (5, 8, 12). Recent reports describe several functionally and
structurally closely related forms ofTGF-# (13-16), and the identities of TGF-
0l (15) to cartilage inducing factor A (CIF-A) (I6) and of TGF-02 (15) to
cartilage inducing factor B (CIF-B) (14). Receptors for TGF-# are ubiquitous (7-
11, 17), and exist in three distinct forms that differentially bind TGF-(3-related
molecules (15). Known effects on the immune system include inhibition of
lymphocyte proliferation, antibody secretion, and NK cell function (10, 11, 17).
We now report that TGF-X31/CIF-A and TGF-,#2/CIF-B are potent inhibitors of
the transition of pre-B cells to mature, functional B cells.
Materials and Methods
Cells.
￿
The murine pre-B cell line, 70Z/3, and the IgMic+ B cell lines, WEHI 231 and
WEHI 279, were maintained in passage in RPMI 1640 supplemented with 10% FCS, 2-
ME, sodium pyruvate, sodium bicarbonate, amino acids, and antibiotics. Single cell
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suspensions of adult B6DIF, (The Jackson Laboratory, Bar Harbor, ME) spleen or bone
marrow were made as described (18). B cells were enriched from the spleens of adult
mice by depletion of adherent cells on Sephadex G-10 columns (18), followed by passage
through nylon wool (19). B cells retained in the column were shaken loose from the nylon
wool and found to be 92% surface is light chain-positive. Bone marrow B cell precursors
were enriched by depletion of B cells on anti-Ig-coated plates (20) and of adherent cells
on a G-10 column as above. B cell-depleted preparations contained <1% K+ cells. For
some experiments, highly enriched B cell precursors were isolated by positive selection
on anti-Ly-5(220) (14.8) coated plates after removal of surface Ig+ (sIg+) cells (20).
Assays.
￿
Bone marrow or spleen cells were assayed for clonable B cells in semi-solid
agar medium containing 25 Ag/ml LPS as described (18). 70Z/3 and bone marrow cells
were analyzed for surface K or class II molecules before and after incubation with soluble
mediators. Cells were stained for 20 min with FITC-anti-a (Southern Biotechnology
Associates, Inc., Birmingham, AL) or unlabeled anti-la' (Becton Dickinson & Co., Moun-
tain View, CA) followed by FITC-anti-IgG2a (Pandex Laboratories, Inc., Mundelein, IL)
for an additional 20 min after two washes. Propidium iodide (P-5264; Sigma Chemical
Co., St. Louis, MO) was added during the last 5 min of labeling to detect dead cells.
Labeled cells were analyzed on an EPICS V (Coulter Electronics Inc., Hialeah, FL) using
Omega 590 SP, BP 527, and BP 630 filters. Dead cells and erythrocytes were gated out
on the basis of propidium iodide uptake and forward angle light scatter. The presence of
TGF-/31 was detected in fixed cells using an anti-TGF-#1 antiserum (21) with an immu-
noperoxidase kit (Zymed Laboratories, San Francisco, CA), or on viable cells by immu-
nofluorescence analysis with FITC-goat anti-rabbit Ig (F-0511 ; Sigma Chemical Co.) as
second antibody. This antiserum does not crossreact with TGF-,82 . Cytoplasmic ji+ pre-B
cells were enumerated as described (20). The phenotypic and functional maturation of B
lineage progenitors in short-term culture was monitored as in our previous reports (18).
RNA Analysis.
￿
Total RNA was prepared from treated cells, slot-blotted, and probed
for K and j chainRNA as described (22). Relative amounts of RNA bands were determined
by densitometric readings.
SolubleMediators.
￿
Bovine TGF-,B1 (CIF-A) and TGF-,82 (CIF-B) (13), factors from the
serum of young NZB mice (NZB-F) (23), and recombinant IL-4 (formerly called BSF-1)
(24) were prepared as described. An additional preparation of TGF-01, purified from
human platelets, and human IL-1 were purchased from R&D Systems, Inc. (Minneapolis,
MN) and Genzyme, Inc. (Boston, MA), respectively. LPS, derived from Staphylococcus
typhosa 0901, was purchased from Difco Laboratories, Inc., Detroit, MI . Recombinant
mouse IFN-y was obtained courtesy of Dr. H. M. Shepard (Genentech, San Francisco,
CA).
Results
Inhibitory Effects of TGF-Q on Cloned Pre-B Cells.
￿
The pre-13 lymphoma cell
line, 70Z/3, produces P heavy chains, has one rearranged K light chain allele,
and can be stimulated to express K by LPS (25-28) . A small percentage, 1-7%,
of 70Z/3 cells maintained in culture medium have detectable surface a, and
typically, incubation with LPS for 48 h resulted in an increase of K+ cells to 77-
90% as determined by channel-by-channel subtraction of cells nonspecifically
stained by FITC-goat-Ig from cells labeled with FITC-goat anti-K. This induc-
tion of x acquisition by LPS was identically inhibited by TGF-,Q1 and TGF-a2 in
a dose-dependent fashion (Fig. 1) . Viability of cells in all cultures after 48 h
incubation was >90% . Cultures containing LPS alone showed some growth
inhibition_ and cell recoveries, determined by counting cells with trypan blue
under a light microscope, were 78-89% of medium controls. Little effect on cell
recoveries of 70Z/3 was noted in cultures containing TGF-al or TGF-,82 alone
(91-105% of medium controls), or together with LPS (96-112% of LPS con-1292 TRANSFORMING GROWTH FACTOR ,B INHIBITION OF PRE-B CELLS
FIGURE 1 .
￿
Inhibitidn of LPS in-
duction of cell surface K expres-
sion. 70Z/3 cells were cultured
for48 hat 0.1 x 106 cells/ml with
LPS (10 FAg/ml) and various con-
centrations of TGF-S1 (Q) or
TGF-02 ("). Cells were then la-
beled with FITC-goat anti-a or
FITC-goat Ig (background con-
trol) andanalyzed by flow cytom-
etry. After subtracting back-
ground staining, 81% of LPS-in-
duced cells and 4% of untreated
cellswere K'. Percentinhibition =
[(percent a' with LPS) - (percent
a' with LPS + TGF) - (percent
K' with medium)]/[(percent K'
TGF Concentration (ng/mL)
￿
with LPS) -(percent K withmedi-
um)].
Log Fluorescence Intensity
FIGURE 2. Inhibition of induction
of LPS, NZB-F, IFN-,y, and IL-1 of
cell surface K. 70Z/3 cells were ana-
lyzed for K expression after culturing
asdescribed in Fig. 1 with no additive
(. . . . ); with LPS (10 ug/ml), NZB-F
(100 U/ml), IFN-,y (50 U/ml), or IL-
1 (25 U/ml) alone (-), or together
with TGF-S1 (10 ng/ml) (--). Similar
results were obtained with TGF-,B2
and humanplatelet-derived TGF-,B1
(not shown).
trols). There was no consistent correlation between cell recovery and the con-
centrations ofTGF-# used.
Light chain expression in response to three other stimuli, IFN-'y, IL-1, and
young NZB mouse serum-derived factors (NZB-F), was also inhibitable by TGF-
0 (Fig. 2). However, while K induction by IL-1, NZB-F, or LPS was completely
abolished, that elicited by IFN-y was not as sensitive to inhibition by either form
of TGF-#. This was also the case when higher concentrations ofinhibitors were
combined with lower doses of IFN-y (data not shown) .
Like LPS, IFN-y did not affect cell viability but was somewhat inhibitory to
cell growth and in several different experiments, cell recoveries after culture
were 80-88% of medium controls. Cell recoveries for TGF-/31 or -02 plus IFN-
7 cultures were similar to those for cultures containing only IFN-'r (92-98% of
IFN-y controls). IL-1 and NZB serum factors alone orin combination with TGF-
# did not affect cell growth or viability.
K RNA Levels in TGF-,Q-treated Cells.
￿
Hybridization with a K gene probe to slot
blots of total RNA isolated from 70Z/3 cells suggests that inhibition of KLog Fluorescence Intensity
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FIGURE 3 .
￿
Inhibition of K RNA levels . 70Z/3
cells were incubated overnight with medium
alone (control), LPS (10 wg/ml), NZB-F (100
U/ml), IL-1 (25 U/ml), IFN-y (50 U/ml), or
IL-4 (labeled as BSF-1 in figure, 400 U/ml)
with or without TGF-01 (10 ng/ml). W279 and
W231 cells were similarly cultured overnight
with or without TGF-fl1 (10 ng/ml) . Total
RNA was extracted, slot-blotted, and probed
for KRNA(A and B) or ju RNA(C and D) .TGF-
S2 was also tested and gave identical results
(not shown).
FIGURE 4. la induction is
not inhibited by TGFO. Class
II antigen expression on
70Z/3 cellswas detected using
anti-Ia mAbs plus FITC-rat
anti-mouse IgG2a after 48 h
incubation with no additive
(a) : TGF-01 (10 ng/ml) (b); IL-
4(400 U/ml) (c); IL-4 +TGF-
,81 (d) ; IFN-y (50 U/ml) (e); or
IFN-y + TGF-01 (f) . Cells
labeled with an irrelevant
monoclonal mouse IgG2a an-
tibody plus FITC-labeled sec-
ond antibody served as back-
ground controls . la was unde-
tectable on uninduced 70Z/3
cells.
expression by TGF-0 may occur by prevention of rc RNA transcription or
accumulation (Fig . 3) . Induction of K RNA in response to LPS, IL-1, and NZB-
F was inhibited by 82, 91, and 95%, respectively, while that mediated by IFN-1'
was decreased by only 21 %. Identical results were obtained using either TGF-
01 or TGF-#2 . In contrast, equivalent amounts ofRNA from the same samples
hybridized with a u heavy chain probe showed no effect of TFG-,B on levels of'
RNA (Fig . 3) .
Enhancement of Class II Antigen Expression .
￿
That TGF-0 is selectively inhibi-
tory was further demonstrated by its effects on class II MHC molecules (la) .
Some subclones of the 70Z/3 line are responsive to IL-4 (formerly called BSF-I)
(29, 30) . Consistent with reported observations (30), transcription of class II
MHC molecules was markedly increased while Ig gene expression was unaffected
(Figs . 3 and 4) . Our recently cloned 70Z/3 line was also inducible for la by IFN-
.y (Fig. 4) but not by IL-1, NZB serum factors, or LPS (data not shown) .
Acquisition of la was not blocked and, in fact, was slightly enhanced by either
form of TGF-a (Fig . 4) . Elevation of la expression by IL-4 on spleen B cells was
similarly not inhibited by TGF-0 (data not shown) .
Inhibition ofBone Marrow B Lineage Cell Maturation .
￿
The inhibitory effects of
TGF-0 were also demonstrable with normal bone marrow cells (Table I) . The1294 TRANSFORMING GROWTH FACTOR 0 INHIBITION OF PRE-B CELLS
TABLE I
TGF-#Inhibits Maturation ofNormal Bone Marrow B Cell Precursors
Unfractionated, B cell-depleted, and B cell-adherent cell-depleted bone marrow cells from 8-wk-
oldmice were cultured at 2 X 106 cells/ml for 48 h in medium alone (control), TGF-,81 (10ng/ml),
NZB-F (100 U/ml), or NZB-F + TGF-fl1 as indicated in the table. Cells were assayed before and
after48-h liquid culture forclonable B cells in semi-solid agar culture with LPS (25 AA/ml), surface
K, and cytoplasmic W expression. B cell colonies were scored after 6 d incubation. Pre-B cells were
enumerated by surface labeling with FITC-goatanti-u, followed by cytospinning and fixing of cells
on glass slides and labeling with tetramethyrhodamine isothiocyanate-goat anti-,u. Cells that were
K-IA' were scored as pre-B cells. Data are expressedas colonies, B cells, or pre-B cells per 105 initial
(preculture) or recovered (after 48-h culture) cells and are representative of similar results from
three other experiments using TGF-#l and TGF-,82.
spontaneous emergence in short-term liquid cultures of mitogen responsive,
surface K+ B cells was stimulated by adherent accessory cells in bone marrow, or
by inclusion of NZB serum factors to adherent cell-depleted bone marrow (18,
23). This was strikingly diminished by TGF-al or TGF-,82 (data not shown for
TGF-a2). In addition, numbers of surface Ig, cytoplasmic A+ cells were signifi-
cantly reduced, indicating that TGF-# may also inhibit generation of pre-B cells.
TGF-# did not significantly affect total cell recoveries after culture as compared
with the controls in each group.
Effects of TGF-,0 on Mature B Cells.
￿
As might be anticipated from a recent
report (11), TGF-,81 and TGF-#2 completely inhibited mitogen-stimulated pro-
liferation ofmature B cells when cultured with the B cells for 6 d in the presence
of LPS in a semi-solid agar cloning assay (Table II). Short-term (1 or 2 h)
exposure ofspleen or bone marrow cells to the factors, followed by a wash, had
no effect (data not shown). In addition, mature B cells in unseparated marrow
suspensions that had been exposed to TGF-,B1 or TGF-a2 for 48 h and washed
still retained functional capability (Table 1).
In contrast to the effects on pre-B cells, no reduction in the density of surface
Igor is RNA was observed after incubating mature splenic B cells or B lymphoma
cells with these factors (Figs. 3 and 5). The average increase in x that follows
LPS stimulation was inhibited (Fig. 5).
Presence of TGF-0 on B Lineage Cells.
￿
TGF-# was easily demonstrable by
Cells
Preculture
B cell
colonies
Total cell
recovery
(percent of
control)
48-h Liquid
B cell
colonies
culture
K` Bcells Pre-Bcells
Unfractionated bone marrow
Control 953 ± 20 902 t 80 21,315 5,145
TGF-,BI 98.2 630 t 10 13,725 2,928
Bcell-depleted bone marrow
Control 8 ± 2 213 t 16 7,722 5,610
TGF-01 94.6 18 ± 2 3,086 2,178
B& adherent cell-depleted
bone marrow
Control 3 ± 1 12 ± 1 1,246 2,836
TGF-$I 105.9 6 t 1 1,446 980
NZB-F 107.7 119 ± 5 10,028 5,504
NZB-F+TGF-01 102.4 19± 1 1,112 1,112LEE ET AL.
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TABLE II
Inhibition of Clonable B Cells in Spleen and Bone Marrow
Discussion
1 127±32 6±3
0.1
￿
1,443 ± 43
￿
257 ± 15
0.01
￿
3,363 ± 30
￿
497 ± 44
Single cell suspensions ofspleen or bone marrow from 8-wk-old mice were
cultured in semi-solid agar medium containing LPS (25 ug/ml) with or
without (control) various concentrations of TGF-B1 or TGF-B2. B cell
colonies (CFU-B) were enumerated after incubation for 6 d.
FIGURE 5. Increase of sur
A
￿
B
￿
face_
￿
K after stimulation, but
not ongoing expression is in- U
￿
hibited in mature B cells. (A)
°
￿
B cells isolated from spleen
m
￿
were incubated for 48 h with
E
￿
c,d
￿
W279
￿
W231
￿
LPS (10 ug/ml), TGF-,B1 (10
z'
￿
a b
￿
e
￿
ng/ml), or LPS + TGF-#1.
Surface K was determined be
Log Fluorescence Intensity
￿
fore and after culture as de-
scribed in Fig. 1. Pre-culture
cells (a); after 48 h culture with TGF-#l (b); medium alone (c); LPS + TGF-01 (d); or LPS (e). (B) is
expression on WEHI 279 or WEHI 231 B lymphoma cells after 48 h culture with (. . . . .) or without
(-) TGF-,B1 (10 ng/ml). TGF-02 gave similar results (not shown).
immunofluorescence, using an antibody recognizing the TGF-,01 form, on the
surface of 70Z/3, WEHI 231 and WEHI 279 cells, and a majority of spleen and
bone marrow nucleated cells. An analysis ofadult bone marrow in four separate
determinations revealed that 59-71% of nucleated cells were positive and this
included populations of B lymphocyte lineage cells. Thus, 70-76% ofcells that
express Ly-5(220) but not surface Ig (total B lineage precursors) and at least
75% of pre-B cells were positive. TGF-# was also demonstrable by immunoper-
oxidase staining on lymphocytes and macrophages but not stromal cells in long-
term bone marrow cultures established according to the Whitlock-Witte proce-
dure, and TGF-0 activity was detectable in these culture supernatants (data not
shown).
This study demonstrates that members of the TGF-,Q family are potent inhib-
itors ofan important step during pre-B cell maturation, acquisition of Ig light
chains, and prevent emergence ofsurface K+, mitogen-responsive B lymphocytes
after in vitro culture of precursor cells. The factors are also antiproliferative
agents formature B lymphocytesand inhibitedthe average increase in K displayed
Inhibitor Amount used
ng/ml
CFU-B/I0'
Spleen
Cells
Bone marrow
Control 5,570 ± 30 895 t 4
TGF-01 10 0 0
1 0 6±3
0.1 394 ± 37 0
0.01 1,320 ± 131 100 ± 21
TGF-,82 10 6 ± 3 01296 TRANSFORMING GROWTH FACTOR 0 INHIBITION OF PRE-B CELLS
by splenic B cells that followed LPS stimulation. However, in contrast to the
inhibition observed in stimulated pre-B and B cells, no reduction in the density
of surface Ig or K RNA was detected after incubating unstimulated, mature
splenic B cells or B lymphoma cells with either TGF-ail or TGF-02. In addition,
levels of u heavy chain RNA were not reduced in pre-B or B cell lines already
constitutively producing j chains. Therefore, initiation of light chain gene
transcription in pre-B cells, and its increase after activation of mature B cells,
but not ongoing Ig RNA synthesis and translation, appear to be TGF-0 sensitive.
Our findings suggest that members ofthe TGF-0 family may selectively influence
gene expression at particular stages of B lineage differentiation.
Under conditions that promote the formation of pre-B and B cells in vitro,
TGF-,Q also decreased the numbers of surface K-, cytoplasmic A' pre-B cells after
short-term culture of bone marrow cells enriched for B lineage precursors.
However, no inhibition was observed in levels of14 RNA in pre-B or B cell lines.
These observations suggest the possibility that TGF-0 might inhibit an earlier
stage of B cell differentiation, initiation of heavy chain gene expression. Experi-
ments are planned to determine if TGF-,Qs have a role in regulation of Ig gene
rearrangement, and/or activation of heavy chain genes.
It will be interesting to investigate the mechanism through which TGF-Os
prevent the accumulation of K mRNA in pre-B cells. While destabilization or
increased degradation of the message is possible, there are several reasons for
suspecting that this is unlikely. There were significant amounts of K RNA in pre-
B cells induced by IFN-,y in the presence of TGF-,0, and levels of message in
established B cell lines were unchanged by these factors. Thus, a very selective
process would have to be invoked, such that message lifespan is dramatically
reduced, but only in cells that receive a particular induction stimulus. Changes
in chromatin state accompanying K transcription have been documented with
our models (28) and TGF-# could be inhibitory at that level. Similarly, activation
ofproteins that bind to the is enhancer (22, 31, 32) might be aborted.
The selective inhibitory activity of TGF-0 was further demonstrated by its
inability to block class II antigen expression. Neither form ofTGF-0 induced la,
but they synergized with IL-4 or IFN--y to enhance class II expression on 70Z/3
pre-B cells. IL-4 did not induce K on 70Z/3 cells (Fig. 3) or enhance acquisition
of K by bone marrow B cell precursors (Lee, G., unpublished observations), while
LPS, IL-1, and NZB serum factors induced a but not la, and IFN-,y enhanced
expression ofboth molecules on 70Z/3 cells. A recent report (30) indicates that
negativeregulation ofclass II expression by maturingpre-Bcellsmay be achieved
with prostaglandins. Taken together with our results, this suggests that the
acquisition of these two functionally significant B cell surface markers, Ig and
la, is independently controlled by particular agonists and antagonists. It is also
noteworthy that K induced by immune interferon was more refractory to down-
regulation by TGF-0 than that induced by other stimuli. Variants of the 70Z/3
cell line have been isolated that are inducible for K by IFN-,y but not LPS (33).
Therefore, activation ofthe same gene may result from different transmembrane
signaling pathways.
Anautocrine regulatory function has been proposed forTGF-0 (34). Activated
B and T cells have increased message and receptors for TGF-a, and the differ-LEE ET AL.
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entiation and/or proliferation of these cells can be inhibited by TGF-# (10, 11).
Most of the TGF-,B produced by various cell types is in a latent, and presumably
precursor form, which becomes functionally potent after acidification (7). Latent
TGF-,61 had no effect on K or Ia induction in our assays (Lee, G., unpublished
observations) and it is not known how the conversion to an active form is
achieved in vivo . TGF-0 was readily detectable by immunofluorescence on the
surface of 70Z/3, WEHI 231, and WEHI 279 cells, a majority of spleen cells,
bone marrow cells, and B cell precursors in bone marrow . Interestingly, TGF-0
activity was also found in supernatants from long-term bone marrow cultures
established according to the Whitlock-Witte procedure (35, and Ellingsworth, L.
R., unpublished observations). The material seemed to be most closely associated
with macrophages and lymphocytes and it may be significant that pre-B cells in
that situation are refractory to maturation-inducing agents (4, 36, and Lee, G.,
unpublished observations). While we did not distinguish passively acquired from
endogenously produced TGF-,B, these findings suggest that maturing precursors
may auto-regulate their maturation in some circumstances. Certainly, the factors
are intimately associated with cells that are potential targets for their action .
Summary
Members of the transforming growth factor (3 (TGF-a) family of polypeptides
were found to be potent in vitro inhibitors of K light chain expression on normal
bone marrow-derived and transformed cloned pre-B cells, and of the maturation
of these cells to mitogen responsiveness. The inhibition by TGF-0 was selective
in that la expression was not blocked. Together with the observations that LPS,
IL-1, NZB serum factors, IL-4, and IFN-y preferentially induced either K or la,
or both, on a pre-B cell line, these results further suggest that acquisition of Ig
andclass II molecules is independentlycontrolled by different antagonists as well
as agonists. In addition, K chain induction by IFN-y does not appear to be as
sensitive to TGF-# downregulation as that stimulated by other factors tested,
and this raises the possibility that activation of the same gene may result from
differenttransm6mbrane signaling pathways. In contrast to the inhibitory effects
of TGF-0 on K acquisition by pre-B cells and on K increase after exposure of
mature B cells to LPS, as measured by K RNA levels and/or surface fluorescence,
no inhibition was observed on unstimulated spleen B cells or on two cloned B
cell lines that constitutively produce K. Thus, TGF-0 may function during specific
stages of B cell differentiation by inhibiting initiation of, or increased transcrip-
tion of Ig genes, and therefore, may be an important negative regulator of B
lymphopoiesis. It is the first natural substance found to have this effect.
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